Individualized testing plansOne specimen type does not need to fit every participant.
Testing frequency and specimen selection can be structured differently depending on whether the participant is entering primary monitoring, continuing testing after formal monitoring, or meeting expectations established by an authorized third party.
Before enrollment, Continuum will clarify the available options and identify any requirements that need to be considered. Participants who require outside acceptance should obtain confirmation from the applicable board, employer, treatment provider, or other requesting organization.
No universal testing claimsQuestions about a specific drug panel, laboratory method, result interpretation, or detection period should be addressed using the specifications applicable to the assigned test. Continuum does not rely on broad one-size-fits-all claims.